Why MorphoSys Shares Are Trading Lower By Around 32%; Here Are 30 Stocks Moving Premarket

Today's Best Finance Deals

Don’t forget to check out our premarket coverage here .

Losers

• MorphoSys AG MOR shares fell 31.8% to $3.74 in pre-market trading. MorphoSys’ licensing partner Roche issued an update on Phase 3 GRADUATE program for Gantenerumab in early Alzheimer’s disease.
• Tremor International Ltd TRMR fell 25.5% to $6.57 in pre-market trading after gaining over 5% on Friday.
• Core Scientific, Inc. CORZ fell 14.2% to $0.1699 in pre-market trading after surging 44% on Friday.
• Fast Radius, Inc. FSRD shares fell 13.5% to $0.2098 in pre-market trading after dropping around 7% on Friday.
• Sterling Infrastructure, Inc. STRL shares fell 9.7% to $28.98 in pre-market trading. Sterling Infrastructure recently reported better-than-expected Q3 results and issued FY22 guidance above estimates.
• Cabaletta Bio, Inc. CABA fell 8.4% to $2.18 in pre-market trading after jumping 17% on Friday. Cabaletta Bio recently posted a Q3 loss of $0.39 per share.
• Amyris, Inc. AMRS fell 8.1% to $2.03 in pre-market trading after jumping 20% on Friday.
• ShiftPixy, Inc. PIXY fell 5.8% to $18.00 in pre-market trading after jumping over 56% on Friday.